Improved pharmacokinetics and enhanced efficacy of the vancomycin derivative FU002 using a liposomal nanocarrier
Julia Werner(Heidelberg University), Philipp Uhl(Heidelberg University), Uwe Haberkorn(German Cancer Research Center), Barbro Beijer(Heidelberg University), Gert Fricker(Heidelberg University), Eric Mühlberg(Heidelberg University), Stefan Zimmermann(Heidelberg University), Christian Kleist(Heidelberg University), Florian Umstätter(Heidelberg University), Tobias Hertlein(University of Würzburg), Knut Ohlsen, Walter Mier(Heidelberg University)
Cited by 11
Related Papers
Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein
|Journal of Nuclear Medicine|2018|908
Engaging neuroscience to advance translational research in brain barrier biology
|Nature reviews. Neuroscience|2011|586
Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo
|Journal of Clinical Investigation|2002|360
Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo
|Journal of Clinical Investigation|2002|345
Phospholipids and Lipid-Based Formulations in Oral Drug Delivery
|Pharmaceutical Research|2010|325